← Leaderboards
Elizabeth A Stewart
Brigham And Women'S Hospital
$4,734,535
Attributed
$6,104,994
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,207,675 · 6
By mechanism
R01$4,437,823 · 2
P50$3,631,561 · 2
RC1$974,131 · 1
K08$164,160 · 1
Top collaborators
- Vanessa Jacoby3 shared
- Wanda K Nicholson3 shared
- Ganesa Rebecca Wegienka3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Marc S Sabatine$10,458,271
- Vesela Kovacheva$1,048,302
- Neculai Archip$541,813
- Thomas A Gaziano$8,815,166
- Nobuhiko Hata$5,976,509
Others in their field
Top investigators on “Uterine Fibroids”
- Evan R. Myers · Duke University$19,951,646
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$10,055,704
- Jose M Teixeira · Massachusetts General Hospital$9,550,215
- Ayman Al-Hendy · University Of Texas Medical Br Galveston$9,015,762
- Serdar E Bulun · Northwestern University$8,654,579
- Lauren A Wise · Boston University Medical Campus$8,308,083
Research focus
Uterine FibroidsFibroid TumorWomanHysterectomyHemorrhagePainSymptomsUterine MyomectomyClinicSymptomatic ImprovementReportingCohortUniversitiesOperative Surgical ProceduresImpairmentSuccessQuality Of LifePregnancyMenopauseMorbidity - Disease RatePressureCaringBlack RaceLocation
Grant awards (16)
COllaboration for EQuity in Uterine Leiomyomas$1,516,960
P50 · FY2025 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$600,362
R01 · FY2025 · HD
Supporting COEQUal projects and personnel: Administrative CORE$230,936
P50 · FY2025 · HD · contact PI
COllaboration for EQuity in Uterine Leiomyomas$1,585,721
P50 · FY2024 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$592,123
R01 · FY2024 · HD
Supporting COEQUal projects and personnel: Administrative CORE$297,944
P50 · FY2024 · HD · contact PI
Long Term Effectiveness of Uterine Sparing Fibroid Treatments$634,794
R01 · FY2023 · HD
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$593,545
R01 · FY2014 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$538,400
R01 · FY2013 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$580,969
R01 · FY2012 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$581,372
R01 · FY2011 · HD · contact PI
Comparing focused ultrasound and uterine artery embolization for uterine fibroids$474,021
RC1 · FY2010 · HD · contact PI
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies$316,258
R01 · FY2010 · HD · contact PI
Comparing focused ultrasound and uterine artery embolization for uterine fibroids$500,110
RC1 · FY2009 · HD · contact PI
MOLECULAR ENDOCRINOLOGY OF THE UTERUS$82,080
K08 · FY2001 · HD
MOLECULAR ENDOCRINOLOGY OF THE UTERUS$82,080
K08 · FY2000 · HD